arrow
C

Carlos Martínez

concordia university - canada
H指数:35
被引数:5,393

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Short- and Medium-Chain Fatty Acid Profiles in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study

活检证实的代谢功能障碍相关脂肪性肝病中短链和中链脂肪酸谱:一项横断面研究

2026-10-290
OA
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity

PARP2 缺乏通过促进基因组不稳定性和抗肿瘤免疫来抑制胰腺癌进展

2026-05-080
OA
ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study

ApoJ和apoL1作为MASH的新型决定因素:一项横断面研究

2025-10-150
OAAI
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer

MET通路抑制可增强小细胞肺癌的化疗-免疫治疗疗效

2025-06-200
OAAI
Alterations in hepatic amino acid metabolism related to MASLD in individuals with obesity

与肥胖个体中MASLD相关的肝脏氨基酸代谢的改变

2025-05-080
PRE
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
2025-01-010
OAAI
Endothelial activation, cell-cell interactions, and inflammatory pathways in postoperative atrial fibrillation following cardiac surgery

内皮激活、细胞间相互作用以及心脏术后房颤中的炎症通路

2024-11-260
OAAI
Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease

肝腐胺水平增加是与代谢功能障碍相关的脂肪性肝病进展相关的新的潜在因素

2024-07-181
PRE
Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics

优化岩藻糖基化人间充质基质细胞在抗炎/免疫调节治疗中的冷冻保存条件

2024-03-280
OAAI
Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity
2024-01-135
OA